Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment
- 1 June 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Endocrinology, Diabetes and Obesity
- Vol. 16 (3) , 203-210
Abstract
Adrenal incidentaloma has become a frequent clinical dilemma. Even in the absence of specific clinical features of Cushing's syndrome, adrenocortical incidentalomas may display steroid secretory activity at different degrees. The recognition of endocrine and metabolic dysfunctions associated with subclinical hypercortisolism leads to current awareness about its potential consequences. Different protocols and threshold values to define normal cortisol secretion and diagnosis of subclinical Cushing's syndrome have been proposed, including recent practice guidelines for the diagnosis of overt Cushing's syndrome. Follow-up studies have provided additional data about the natural course of the disease and related cardiovascular and metabolic consequences. The study of bilateral adrenocorticotropin-independent macronodular adrenocortical hyperplasia in some familial cases offers a new approach to understanding the spectrum of subclinical cortisol hypersecretion. The prevalence of subclinical hypercortisolism may be higher than previously reported as more sensitive diagnostic criteria are now recommended. The absence of a single gold standard test, the diversity of diagnostic criteria and the requirement of subsequent meticulous biochemical evaluations before a decision for treatment represent a challenge for the clinical management of this condition.Keywords
This publication has 70 references indexed in Scilit:
- The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2008
- Clinical and Subclinical ACTH-Independent Macronodular Adrenal Hyperplasia and Aberrant Hormone ReceptorsHormone Research in Paediatrics, 2005
- Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical studyClinical Endocrinology, 2004
- Prevalence of Subclinical Cushing's Syndrome in 70 Patients with Adrenal Incidentaloma: Clinical, Biochemical and Surgical OutcomesEndocrine Journal, 2003
- The Ectopic Expression of the Gastric Inhibitory Polypeptide Receptor Is Frequent in Adrenocorticotropin-Independent Bilateral Macronodular Adrenal Hyperplasia, but Rare in Unilateral TumorsThe Journal of Clinical Endocrinology & Metabolism, 2002
- Aberrant Membrane Hormone Receptors in Incidentally Discovered Bilateral Macronodular Adrenal Hyperplasia with Subclinical Cushing's SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2001
- Autonomy of Cortisol Secretion in Clinically Silent Adrenal IncidentalomaHormone and Metabolic Research, 2001
- Ectopic and Abnormal Hormone Receptors in Adrenal Cushing's SyndromeEndocrine Reviews, 2001
- Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumourClinical Endocrinology, 1995
- Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndromeThe Journal of Clinical Endocrinology & Metabolism, 1992